Spatial distribution of glucose hypometabolism induced by intracerebroventricular streptozotocin in monkeys

Journal of Alzheimer's Disease

Volumn 25, Issue 3, 2011, Pages 517-523

  Heo, Jae Hyeok ^a   Lee, Sang Rae ^b   Lee, Soon Tae ^c   Lee, Kyoung Min ^c   Oh, Jin Hwan ^d   Jang, Dong Pyo ^d   Chang, Kyu Tae ^b   Cho, Zang Hee ^d  

^a Seoul Medical Center   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Gachon University College of Medicine   (South Korea)

Author keywords

Alzheimer's disease; cynomolgus; streptozotocin induced AD model

Indexed keywords

FLUORODEOXYGLUCOSE F 18; STREPTOZOCIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; BRAIN ATROPHY; CISTERNA MAGNA; CONTROLLED STUDY; EXPERIMENTAL MONKEY; GLUCOSE METABOLISM; HYPOMETABOLISM; MIDDLE TEMPORAL GYRUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRECUNEUS; PRIORITY JOURNAL;

EID: 79960787962     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-102079     Document Type: Article

References (17)

1. Estrada LD, Soto C (2007) Disrupting fj-amyloid aggregation for Alzheimer disease treatment. Curr Topics Med Chem 7, 115-126. (Pubitemid 46062400)
2. Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM (2006) Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. J Alzheimers Dis 9, 13-33.
3. Salkovic-Petrisic M, Osmanovic J, Grunblatt E, Riederer P, Hoyer S (2009) Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term mor-phobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta. J Alzheimers Dis 18, 729-750.
4. Chetelat G, Desgranges B, Landeau B, Mezenge F, Poline JB, de la Sayette V, Viader F, Eustache F, Baron JC (2008) Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain 131, 60-71.
5. Kim J, Avants BB, Patel S, Whyte J, Coslett BH, Pluta J, Detre A, Gee JC (2008) Structural consequences of diffuse traumatic brain injury: a large deformation tensor-based morphometry study. Neuro Image 39, 1014-1026.
6. Mistur R, Mosconi L, Santi SD, Guzman M, Li Y, Tsui W, de Leon MJ (2009) Current challenges for the early detection of Alzheimer's disease: Brain imaging and CSF studies. J Clin Neurol 5, 153-166.
7. Herholz K, Carter SF, Jones M (2007) Positron emission tomography imaging in dementia. Br J Radiol 2, 160-167.
8. Guo X, Wang Z, Li K, Li Z, Qi Z, Jin Z, Yao L, Chen K (2010) Voxel-based assessment of gray and white matter volumes in Alzheimer's disease. Neurosci Lett 468, 146-150.
9. Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P (2006) Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J Neurochem 96, 1005-1015.
10. Deng Y, Li B, Liu Y, Iqbal K, Grundke-Iqbal I, Gong CX (2009) Dysregulation of insulin signaling, glucose trans porters, O-Glc NAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's dis ease. Am J Pathol 175, 2089-2098.
11. Schubert M, Gautam D, Surjo D, Ueki K, Baudler S, Schubert D, Kondo T, Alber J, Galldiks N, Kustermann E, Arndt S, Jacobs AH, Krone W, Kahn CR, Bruning JC (2004) Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci USA 101, 3100-3105. (Pubitemid 38327741)
12. Rivera E, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM (2005) Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: Link to brain redutions in acetylcholine. J Alzheimers Dis 8, 247-268.
13. Garcia MA, Millan C, Balmaceda-Aguilera C, Castro T, Pastor P, Montecinos H, Reinicke K, Zuniga F, Vera JC, Onate SA, Nualart F (2003) Hypothalamic ependymal-glial cells express the glucose transporter GLUT2, a protein involved in glucose sensing. J Neurochem 86, 709-724. (Pubitemid 36897451)
14. Grunblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S (2007) Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem 101, 757-770. (Pubitemid 46633313)
15. Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S (2011) Insulin resistance and Alzheimer like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early teype 2 diabetes. Arch Neurol 68, 51-57.
16. Edison P, Archer HA, Hinz R, Hammers A, Paverse N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ (2007) Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology 68, 501-508.
17. Tolboom N, Yaqub M, van der Flier WM, Boellaard R, Luurtsema G, Windhorst AD, Barkhof F, Scheltens P, Lammertsma AA, van Berckel BN (2009) Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET. J Nucl Med 50, 191-197.